The Australian and New Zealand College of Anaesthetists (ANZCA) and peak diabetes, obesity and gastroenterological bodies have updated recommendations, frequently asked questions (FAQs) and patient information for clinicians when talking to patients using GLP-1/GIP receptor agonists
Semaglutide and tirzepatide were added to the Monitoring Program to track patterns of use in sports in and out of competition
Sironen, A., Shoemark, A., Patel, M., Loebinger, M
Unknown, V
Its affordable, tracks heart rate in real time, is water- and dust-resistant, and is compatible with over 200 apps and fitness platforms
We suggest that, with encouraging evidence of therapeutic effects and increasing insights into the mechanisms of action, randomized controlled trials should be conducted to elucidate a foundation for the clinical use of the KD